Viewing Study NCT01307527


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-01 @ 10:45 PM
Study NCT ID: NCT01307527
Status: UNKNOWN
Last Update Posted: 2011-03-03
First Post: 2011-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI
Sponsor: Hadassah Medical Organization
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module